Lipids in cancer: a global view of the contribution of lipid pathways to metastatic formation and treatment resistance - Aix-Marseille Université Access content directly
Journal Articles (Review Article) Oncogenesis Year : 2022

Lipids in cancer: a global view of the contribution of lipid pathways to metastatic formation and treatment resistance

Abstract

Lipids are essential constituents for malignant tumors, as they are absolutely required for tumor growth and dissemination. Provided by the tumor microenvironment (TME) or by cancer cells themselves through activation of de novo synthesis pathways, they orchestrate a large variety of pro-tumorigenic functions. Importantly, TME cells, especially immune cells, cancer-associated fibroblasts (CAFs) and cancer-associated adipocytes (CAAs), are also prone to changes in their lipid content, which hinder or promote tumor aggressiveness. In this review, we address the significant findings for lipid contribution in tumor progression towards a metastatic disease and in the poor response to therapeutic treatments. We also highlight the benefits of targeting lipid pathways in preclinical models to slow down metastasis development and overcome chemo-and immunotherapy resistance.
Fichier principal
Vignette du fichier
Vasseur and Guillaumond (2022) Oncogenesis.pdf (2.03 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive

Dates and versions

hal-03962099 , version 1 (30-01-2023)

Licence

Attribution

Identifiers

Cite

Sophie Vasseur, Fabienne Guillaumond. Lipids in cancer: a global view of the contribution of lipid pathways to metastatic formation and treatment resistance. Oncogenesis, 2022, 11, ⟨10.1038/s41389-022-00420-8⟩. ⟨hal-03962099⟩

Collections

CNRS UNIV-AMU CRCM
41 View
25 Download

Altmetric

Share

Gmail Facebook X LinkedIn More